Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-29 Option Award |
2021-02-02 8:26 pm |
N/A 2031-01-28 |
Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President |
460,000 | $0 | 460,000 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 06:23 am |
N/A 2030-11-29 |
Rubius Therapeutics Inc. | RUBY | Carmona Jose Chief Financial Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 8:52 pm |
N/A 2030-05-20 |
Rubius Therapeutics Inc. | RUBY | Holles Natalie C. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 7:25 pm |
N/A 2030-05-20 |
Rubius Therapeutics Inc. | RUBY | Cuss Francis M Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 7:25 pm |
N/A 2030-05-20 |
Rubius Therapeutics Inc. | RUBY | Rosenblatt Michael Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 7:24 pm |
N/A 2030-05-20 |
Rubius Therapeutics Inc. | RUBY | Sohn Catherine A. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 7:24 pm |
N/A 2030-05-20 |
Rubius Therapeutics Inc. | RUBY | AFEYAN NOUBAR Director 10% Owner |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 7:24 pm |
N/A 2030-05-20 |
Rubius Therapeutics Inc. | RUBY | Symonds Jonathan Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 7:24 pm |
N/A 2030-05-20 |
Rubius Therapeutics Inc. | RUBY | Epstein David R Director |
115,771 | $0 | 115,771 (Direct) |
View |
| 2020-05-15 Exercise |
2020-05-19 8:02 pm |
N/A N/A |
Rubius Therapeutics Inc. | RUBY | OH ANDREW M. Chief Financial Officer |
5,000 | $4.74 | 760,500 (Direct) |
View |
| 2020-05-15 Exercise |
2020-05-19 8:02 pm |
N/A 2028-02-14 |
Rubius Therapeutics Inc. | RUBY | OH ANDREW M. Chief Financial Officer |
5,000 | $0 | 760,500 (Direct) |
View |